Nuvation Bio Inc. (NUVB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 5.07M | -29.73M | -52.89M | -48.18M | -42.63M | -46.3M | -31.09M | -37.32M | -15.7M | -15.03M | -16.16M | -17.48M |
| Operating CF Margin % | 6.09% | -71.02% | -403.12% | -996.86% | -1382.2% | -810.75% | -4275.79% | -2600.98% | - | - | - | - |
| Operating CF Growth % | 111.89% | 35.78% | -70.14% | -29.08% | -171.47% | -208.08% | -92.42% | -113.46% | 18.77% | 7.05% | 42.49% | 35.04% |
| Net Income | 5.4M | 168.03M | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M | -19.65M | -20.64M |
| Depreciation & Amortization | 536K | -1.2M | 534K | 356K | 310K | 219K | 162K | 244K | 58K | 55K | 55K | 56K |
| Stock-Based Compensation | 9.03M | -27.91M | 8.02M | 12.03M | 7.85M | 10.19M | 7.48M | 9.57M | 5.04M | 3.72M | 5.43M | 5.52M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.6M | -174.37M | 3M | -1.75M | -314K | -519K | -2.48M | 421.48M | -1.4M | -3.58M | -3.82M | -2.88M |
| Working Capital Changes | -11.5M | 5.7M | -8.66M | 194K | 2.76M | -6.75M | 4.97M | -6.12M | -4.61M | -1.44M | 1.83M | 451K |
| Change in Receivables | -6.62M | -2.44M | -7.17M | -1.22M | 10.83M | -12.04M | -240K | 272K | -581K | -669K | -238K | -522K |
| Change in Inventory | -4.43M | 5.71M | -5.16M | -538K | -14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 12.96M | -9.01M | -7.06M | 11.88M | 4.19M | -6.03M | 7.17M | -3.02M | 227K | -164K | -204K | -368K |
| Cash from Investing | -43.64M | 87.08M | -96.62M | 54.88M | 54.18M | 51.77M | 29.12M | 34.27M | 7.54M | 33.16M | -9.59M | 37.35M |
| Capital Expenditures | -48K | 8.27M | -8.01M | -181K | -72K | 13K | -148K | 0 | -27K | -13K | -22K | -22K |
| CapEx % of Revenue | 0.06% | 19.74% | 61.07% | 3.75% | 2.33% | 0.23% | 20.36% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -92K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 99.52M | 0 | 0 | 0 | 0 | 0 | 12.52M | 0 | 14K | 0 | 0 |
| Cash from Financing | 44K | 8.06M | 501K | 193.42M | 548K | -900K | -1.54M | 2.75M | 21K | 120K | 77K | 133K |
| Debt Issued (Net) | 0 | -191.54M | -6.66M | 198.74M | -534K | -2.06M | -3.21M | 713K | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 908K | -1.85M | 558K | 1.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -864K | 201.45M | 6.61M | -6.61M | 1.08M | 1.16M | 1.67M | 2.04M | 21K | 120K | 77K | 133K |
| Net Change in Cash | -38.7M | 65.19M | -149.07M | 199.99M | 12.25M | 5.69M | -4.25M | -225K | -8.14M | 18.25M | -25.67M | 19.99M |
| Free Cash Flow | 5.02M | -29.82M | -52.9M | -48.36M | -42.7M | -46.29M | -31.23M | -37.32M | -15.73M | -15.04M | -16.18M | -17.51M |
| FCF Margin % | 6.03% | -71.23% | -403.21% | -1000.6% | -1384.53% | -810.52% | -4296.15% | -2600.98% | - | - | - | - |
| FCF Growth % | 111.76% | 35.57% | -69.38% | -29.57% | -171.47% | -207.73% | -93.07% | -113.19% | 18.68% | 7.34% | 42.62% | 35.43% |
| FCF per Share | 0.01 | -0.09 | -0.15 | -0.14 | -0.13 | -0.14 | -0.11 | -0.15 | -0.07 | -0.07 | -0.07 | -0.08 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.81x | 0.95x | 0.82x | 0.80x | 0.94x | 0.75x | 0.08x | 1.06x | 1.09x | 0.82x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |